Literature DB >> 215685

Purification of polyphosphoinositides by chromatography on immobilized neomycin.

J Schacht.   

Abstract

The binding of polyphosphoinositides (phosphatidylinositol phosphate and phosphatidylinositol bisphosphate) to the antibiotic neomycin is utilized for the purification of these lipids. Neomycin is reductively coupled to reactive glass beads (Glycophase-CPG) and serves as the stationary phase in column chromatography. A total lipid extract is prepared from tissues with chloroform-methanol-KC1 or chloroform-methanol-HC1 and washed once with acidified methanol-water. After the addition of an equal volume of methanolic 200 mM ammonium acetate, the extract is directly applied to the column. All lipids but the polyphosphoinositides are removed from the column by rinsing with 150 mM ammonium acetate in chloroform-methanol-water. Increasing the salt concentration to 600 mM elutes phosphatidylinositol phosphate. While further increases in ionic strength are not sufficient for a quantitative removal of phosphatidylinositol bisphosphate, the lipid is completely eluted by the addition of either ammonia or HC1 to the solvent. The column can be recycled and used repeatedly.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215685

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  71 in total

1.  Purification and characterization of human erythrocyte phosphatidylinositol 4-kinase. Phosphatidylinositol 4-kinase and phosphatidylinositol 3-monophosphate 4-kinase are distinct enzymes.

Authors:  A Graziani; L E Ling; G Endemann; C L Carpenter; L C Cantley
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  Identification of nuclear phosphatidylinositol 4,5-bisphosphate-interacting proteins by neomycin extraction.

Authors:  Aurélia E Lewis; Lilly Sommer; Magnus Ø Arntzen; Yvan Strahm; Nicholas A Morrice; Nullin Divecha; Clive S D'Santos
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

3.  Guanine-nucleotide and hormone regulation of polyphosphoinositide phospholipase C activity of rat liver plasma membranes. Bivalent-cation and phospholipid requirements.

Authors:  S J Taylor; J H Exton
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

4.  Synergistic activation of phospholipase D by protein kinase C- and G-protein-mediated pathways in streptolysin O-permeabilized HL60 cells.

Authors:  B Geny; S Cockcroft
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

5.  Dissociation of phosphoinositide hydrolysis and positive inotropic effect of histamine mediated by H1-receptors in guinea-pig left atria.

Authors:  Y Hattori; M Endou; M Shirota; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

6.  Polyphosphoinositide Phospholipase C in Plasma Membranes of Wheat (Triticum aestivum L.) : Orientation of Active Site and Activation by Ca and Mg.

Authors:  C Pical; A S Sandelius; P M Melin; M Sommarin
Journal:  Plant Physiol       Date:  1992-11       Impact factor: 8.340

7.  Stabilization of erythrocyte membranes by polyamines.

Authors:  S K Ballas; N Mohandas; L J Marton; S B Shohet
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

8.  Neomycin does not interfere with the inositol phospholipid metabolism, but blocks binding of alpha-thrombin to intact human platelets.

Authors:  O B Tysnes; E Johanessen; V M Steen
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

9.  Receptor-mediated metabolism of the phosphoinositides and phosphatidic acid in rat lacrimal acinar cells.

Authors:  P P Godfrey; J W Putney
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

10.  The role of the phosphatidylinositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli alpha-haemolysin, thrombin and fluoride.

Authors:  B König; W König
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.